rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mark Stetter

Director

Company insider

Files Form 4 as: Director, Zoetis.

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
21 May 2025
Last trade
17 Sep 2026
Last filed
18 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ZTS ZoetisDirector · Pharmaceuticals · last 17 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
17 Sep 2026filed 18 Sep 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$25K342.372 at $73.02filing
17 Sep 2026filed 18 Sep 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$25K342.37 at $73.02filing
18 Jun 2026filed 22 Jun 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$25K317.622 at $78.71filing
18 Jun 2026filed 22 Jun 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$25K317.62 at $78.71filing
21 May 2026filed 26 May 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code M—1,572filing
21 May 2026filed 26 May 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,572.061filing
21 May 2026filed 26 May 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,572.06filing
21 May 2026filed 26 May 2026ZTS ZoetisPharmaceuticalsSEC FORM 4 Code M—1,572filing
19 Mar 2026filed 20 Mar 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$25K215.536 at $115.99filing
19 Mar 2026filed 20 Mar 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$25K215.54 at $115.99filing
18 Feb 2026filed 19 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A—1,936 at $0.00filing
18 Feb 2026filed 19 Feb 2026ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A—1,936 at $0.00filing
21 May 2025filed 22 May 2025ZTS Zoetisoption or derivative · PharmaceuticalsSEC FORM 4 Code A$250K1,548 at $161.44filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Roxanne LaganoExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Kevin EschExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Keith SarbaughExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Rimma DriscollExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year
Astorga Jeannette FerranExecutive Vice President · Executive Vice President at Zoetis, filing Form 4 there in the last year